acquaintances via the Internet. I can not vouch for its accuracy. |
Covering Brokerages: Advest Inc., Dain Rauscher Wessels Inc., Donaldson Lufkin and Jenrette Securities Corp., Goldman Sachs and Co., Prudential Securities Inc., Raymond James Financial, Inc., SG Cowen Securities Corp.
|
1Q Conference Call 4/17/00 S G Cowen 2/15/00 (Buy) Re-initiated coverage Prudential 2/11/00 Downgrade: Accumulate to Hold. DLJ 2/11/00 (Buy) Reiterate Buy rating. Raymond James 2/11/00 Downgrade: Buy to Market Performer 4Q Conference Call 2/10/00 Prudential 12/28/99 Downgrade from Strong Buy to Accumulate. Raymond James 12/9/99 Initiating Coverage at Accumulate. KeraVision Company's response to the Goldman, Sachs survey. An email from the company. ISRS survey 10/25/99 ISRS survey: More surgeons expect to incorporate Intacs into their practice. 3Q Conference Call 10/19/99 600,000 shares issued - over-allotment provision of August offering - 9/2/99 DLJ 8/23/99 Initiating Coverage With a Buy Rating. Prudential 8/13/99 Coverage Initiated as Strong Buy. 4,000,000 share follow-on offering issued 8/12/99 Advest 6/2/99 Coverage Initiated as Buy Goldman, Sachs 4/22/99 Downgrade from RL to MO. Intacs approved by FDA 4/9/99 Dain Rauscher 4/8/99 Coverage Initiated as Buy |
Essay:The Intacs™ Proposition